Sodium Channel Myotonia Due to Novel Mutations in Domain I of Na

Nav 1.4 channelopathy founder effect mexiletine myotonia sodium channel myotonia

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 23 12 2019
accepted: 17 03 2020
entrez: 16 5 2020
pubmed: 16 5 2020
medline: 16 5 2020
Statut: epublish

Résumé

Sodium channel myotonia is a form of muscle channelopathy due to mutations that affect the Na

Identifiants

pubmed: 32411069
doi: 10.3389/fneur.2020.00255
pmc: PMC7201054
doi:

Types de publication

Journal Article

Langues

eng

Pagination

255

Informations de copyright

Copyright © 2020 Pagliarani, Lucchiari, Scarlato, Redaelli, Modoni, Magri, Fossati, Previtali, Sansone, Lecchi, Lo Monaco, Meola and Comi.

Références

Neurol Sci. 2005 Oct;26(4):194-202
pubmed: 16193245
Compr Physiol. 2013 Apr;3(2):599-653
pubmed: 23720324
Handb Exp Pharmacol. 2018;246:309-330
pubmed: 28939973
Curr Opin Neurol. 2014 Oct;27(5):583-90
pubmed: 25188014
Neurology. 2008 Nov 18;71(21):1669-75
pubmed: 19015483
Neurology. 2007 Nov 13;69(20):1937-41
pubmed: 17998485
Ann Neurol. 1997 Nov;42(5):811-4
pubmed: 9392583
Curr Opin Neurol. 2010 Oct;23(5):466-76
pubmed: 20634695
Lancet. 2018 Apr 14;391(10129):1483-1492
pubmed: 29605429
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12785-9
pubmed: 7809121
Brain. 2010 Jan;133(Pt 1):9-22
pubmed: 19917643
Muscle Nerve. 2010 Apr;41(4):470-7
pubmed: 19882638
Neurology. 2001 Apr 10;56(7):878-84
pubmed: 11294924
Neurology. 2010 Aug 17;75(7):641-5
pubmed: 20713951
Ann Neurol. 2006 Sep;60(3):356-65
pubmed: 16786525
Sci Rep. 2019 Nov 26;9(1):17560
pubmed: 31772215
Eur J Hum Genet. 2008 Aug;16(8):921-9
pubmed: 18337730
Brain. 2016 Mar;139(Pt 3):674-91
pubmed: 26700687

Auteurs

Serena Pagliarani (S)

Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Sabrina Lucchiari (S)

Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Marina Scarlato (M)

Department of Neurology and INSPE, IRCCS Ospedale San Raffaele, Milan, Italy.

Elisa Redaelli (E)

Department of Biotechnology and Biosciences, University of Milano - Bicocca, Milan, Italy.

Anna Modoni (A)

Institute of Neurology, Area of Neuroscience, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Francesca Magri (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.

Barbara Fossati (B)

Department of Neurorehabilitation Sciences, casa di Cura del Policlinico, Milan, Italy.

Stefano C Previtali (SC)

Department of Neurology and INSPE, IRCCS Ospedale San Raffaele, Milan, Italy.

Valeria A Sansone (VA)

Neurorehabilitation Unit, University of Milan; The NEMO (NEuroMuscular Omniservice) Clinical Center, Milan, Italy.

Marzia Lecchi (M)

Department of Biotechnology and Biosciences and Milan Center for Neuroscience, University of Milano - Bicocca, Milan, Italy.

Mauro Lo Monaco (M)

Institute of Neurology, Area of Neuroscience, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
MIA (Myotonics in Association), Portici, Italy.

Giovanni Meola (G)

Department of Neurorehabilitation Sciences, casa di Cura del Policlinico, Milan, Italy.

Giacomo P Comi (GP)

Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neuromuscular and Rare Diseases Unit, Milan, Italy.

Classifications MeSH